148 related articles for article (PubMed ID: 2283330)
1. [Role of the tumor marker TAG-72 in head and neck neoplasms].
Altissimi G; von Garrel C
HNO; 1990 Oct; 38(10):364-6. PubMed ID: 2283330
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
Arlt A; Luckhaupt H; Hildmann H
Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
[TBL] [Abstract][Full Text] [Related]
3. Cyfra 21-1 as a serum tumor marker for follow-up of patients with laryngeal and hypopharyngeal squamous cell carcinoma.
Al-Shagahin H; Alkotyfan K; Müller HH; Sesterhenn AM; Werner JA
Anticancer Res; 2009 Aug; 29(8):3421-5. PubMed ID: 19661367
[TBL] [Abstract][Full Text] [Related]
4. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].
Fischer F; Egg G
HNO; 1990 Oct; 38(10):361-3. PubMed ID: 2283329
[TBL] [Abstract][Full Text] [Related]
5. [Study of Cyfra 21-1 as a new tumor marker for the diagnosis of epidermoid carcinoma of the head and neck].
González Sánchez E; López-Ríos Velasco J; Calvo Boizas E; García-Talavera Fernández JR; Martín Ro-dríguez M; Muñoz Herrera A; Del Cañizo Alvarez A
Acta Otorrinolaringol Esp; 1999 Mar; 50(2):85-9. PubMed ID: 10217679
[TBL] [Abstract][Full Text] [Related]
6. [The SCC antigen is not a reliable tumor marker in the ENT area. Value of squamous cell carcinoma antigen in diagnosis and follow-up of squamous epithelial carcinoma in the head-neck area. Results of a retrospective study over 6 years].
Gotschuli A; Anderhuber W; Danninger R; Habermann W
Laryngorhinootologie; 1998 Mar; 77(3):165-7. PubMed ID: 9577824
[TBL] [Abstract][Full Text] [Related]
7. [Squamous cell carcinoma antigen. Current clinical value of a new tumor marker in head and neck cancer; preliminary results of a prospective study after 12 months].
Clasen B; Roettger D; Senekowitsch R; Menz E
Laryngol Rhinol Otol (Stuttg); 1988 Aug; 67(8):420-5. PubMed ID: 3210877
[TBL] [Abstract][Full Text] [Related]
8. [Relevance of the new tumor marker SCC (squamous cell carcinoma antigen) for the diagnosis and follow-up control of squamous epithelial carcinoma of the head and neck].
Koch T; Eiffert H; Spindler MB
HNO; 1989 Nov; 37(11):454-9. PubMed ID: 2584067
[TBL] [Abstract][Full Text] [Related]
9. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
[TBL] [Abstract][Full Text] [Related]
10. Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma.
Deng YF; Chen P; Lin YZ; Le JZ; Wu XL; Yu MQ; Zhuang PY; Gao MH
J Laryngol Otol; 2003 Mar; 117(3):190-4. PubMed ID: 12648374
[TBL] [Abstract][Full Text] [Related]
11. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma.
Kim CH; Lee JS; Kang SO; Bae JH; Hong SP; Kahng H
Oral Oncol; 2007 Nov; 43(10):1021-5. PubMed ID: 17306605
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of head and neck cancer.
Smith R
J Okla State Med Assoc; 1974 Apr; 67(4):128-33. PubMed ID: 4826107
[No Abstract] [Full Text] [Related]
13. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
Eibling DE; Johnson JT; Wagner RL; Su S
Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
[TBL] [Abstract][Full Text] [Related]
14. The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck.
Pauli C; Stieber P; Schmitt UM; Andratschke M; Hoffmann K; Wollenberg B
Anticancer Res; 2002; 22(5):3093-7. PubMed ID: 12530049
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of elevated osteopontin levels in head and neck cancer patients.
Eto M; Kodama S; Nomi N; Uemura N; Suzuki M
Auris Nasus Larynx; 2007 Sep; 34(3):343-6. PubMed ID: 17254728
[TBL] [Abstract][Full Text] [Related]
16. RCAS-1 serum and tumor levels in head and neck squamous cell carcinoma.
Brunner M; Erovic B; Heiduschka G; Schneider S; Pammer J; Frantal S; Thurnher D
Eur Surg Res; 2010; 44(3-4):214-9. PubMed ID: 20571277
[TBL] [Abstract][Full Text] [Related]
17. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
Wollenberg B; Jan V; Schmit UM; Hofmann K; Stieber P; Fateh-Moghadam A
Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778
[TBL] [Abstract][Full Text] [Related]
18. p53 autoantibodies as tumor marker in head and neck squamous cell cancer.
Gottschlich S; Hoffmann M; Maass JD; Görörgh T; Buhmann V; Hoffmann-Fazel A; Rudert H; Maune S
Anticancer Res; 2003; 23(2A):913-5. PubMed ID: 12820322
[TBL] [Abstract][Full Text] [Related]
19. [Serum dihydrotestosterone versus total testosterone values of patients with laryngeal carcinomas and chronic laryngitis].
Kleemann D; Kunkel S
Laryngorhinootologie; 1996 Jun; 75(6):351-5. PubMed ID: 8766382
[TBL] [Abstract][Full Text] [Related]
20. [CEA studies in squamous cell carcinomas of the head and neck].
Schröder M; Meyer T
HNO; 1986 Aug; 34(8):334-42. PubMed ID: 3759515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
